|
|
Volumn 1, Issue 4, 2004, Pages 397-403
|
|
Skin lipid synthesis inhibition: a possible means for enhancing percutaneous delivery of levodopa.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
3 CHLOROALANINE;
3-CHLOROALANINE;
ALCOHOL;
ANTIPARKINSON AGENT;
ATORVASTATIN;
BETA ALANINE;
CALCIUM CHANNEL BLOCKING AGENT;
CALCIUM CHLORIDE;
CHOLESTEROL;
DRUG DERIVATIVE;
HEPTANOIC ACID DERIVATIVE;
HYPOCHOLESTEROLEMIC AGENT;
LEVODOPA;
PYRROLE DERIVATIVE;
SERINE PALMITOYLTRANSFERASE;
SPHINGOSINE;
VERAPAMIL;
ANIMAL;
ARTICLE;
BIOSYNTHESIS;
CHEMISTRY;
COMPARATIVE STUDY;
DOSE RESPONSE;
DRUG ANTAGONISM;
DRUG EFFECT;
FEMALE;
IN VITRO STUDY;
INTRADERMAL DRUG ADMINISTRATION;
MALE;
METABOLISM;
RAT;
SKIN;
TIME;
WISTAR RAT;
ADMINISTRATION, CUTANEOUS;
ANIMALS;
ANTICHOLESTEREMIC AGENTS;
ANTIPARKINSON AGENTS;
BETA-ALANINE;
CALCIUM CHANNEL BLOCKERS;
CALCIUM CHLORIDE;
CHOLESTEROL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
ETHANOL;
FEMALE;
HEPTANOIC ACIDS;
LEVODOPA;
MALE;
PYRROLES;
RATS;
RATS, WISTAR;
SERINE C-PALMITOYLTRANSFERASE;
SKIN;
SPHINGOSINE;
TIME FACTORS;
VERAPAMIL;
|
|
EID: 27744479418
PISSN: 15672018
EISSN: None
Source Type: Journal
DOI: 10.2174/1567201043334579 Document Type: Article |
|
Times cited : (13)
|
|
References (0)
|
